These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5752577)

  • 1. [Studies on the hydrolysis of glucuronolactone in phosphate buffer solutions].
    Yamana T; Mizukami Y; Ichimura F
    Yakugaku Zasshi; 1968 Dec; 88(12):1504-11. PubMed ID: 5752577
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the hydrolysis of glucuronamide in phosphate buffer solutions].
    Yamana T; Mizukami Y; Ichimura F
    Yakugaku Zasshi; 1969 Feb; 89(2):173-81. PubMed ID: 5815510
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of the WATR technique for water suppression in 1H NMR spectroscopy in determination of the kinetics of hydrolysis of neostigmine bromide in aqueous solution.
    Ferdous AJ; Waigh RD
    J Pharm Pharmacol; 1993 Jun; 45(6):559-62. PubMed ID: 8103105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stability of trifluorothymidine: hydrolysis in buffered aqueous solutions.
    Jones MF
    J Pharm Pharmacol; 1981 May; 33(5):274-8. PubMed ID: 6116773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FACTORS INFLUENCING STABILITY OF PREDNISOLONE IN AQUEOUS SOLUTION.
    OESTERLING TO; GUTTMAN DE
    J Pharm Sci; 1964 Oct; 53():1189-92. PubMed ID: 14249434
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics.
    Grit M; Zuidam NJ; Underberg WJ; Crommelin DJ
    J Pharm Pharmacol; 1993 Jun; 45(6):490-5. PubMed ID: 8103093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution stability of ciclosidomine.
    Carney CF
    J Pharm Sci; 1987 May; 76(5):393-7. PubMed ID: 3656101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of pH and tonicity of pharmaceutical buffers at 37 degrees.
    Cutie AJ; Sciarrone BJ
    J Pharm Sci; 1969 Aug; 58(8):990-3. PubMed ID: 5344537
    [No Abstract]   [Full Text] [Related]  

  • 9. Physicochemical stability of pharmaceutical phosphate buffer solutions III. Gel filtration chromatography of Al(III) complex formed in phosphate buffer solutions.
    Hasegawa K; Hashi K; Okada R
    J Parenter Sci Technol; 1982; 36(4):174-8. PubMed ID: 6813448
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions.
    Zhou M; Notari RE
    J Pharm Sci; 1995 May; 84(5):534-8. PubMed ID: 7658340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrolysis of nicotinyl 6-aminonicotinate.
    Wang JC; Patel B
    J Pharm Sci; 1986 Feb; 75(2):204-7. PubMed ID: 3958934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of pH, temperature and buffers on the degradation kinetics of cefetamet pivoxil hydrochloride in aqueous solutions.
    Jelińska A; Dobrowolski L; Oszczapowicz I
    J Pharm Biomed Anal; 2004 Sep; 35(5):1273-7. PubMed ID: 15336372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability.
    Pramar Y; Gupta VD
    J Pharm Sci; 1991 Jun; 80(6):551-3. PubMed ID: 1941547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of pH and temperature on the degradation kinetics of 4-methoxy-2-[3-(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c] pyridine in aqueous solutions.
    Muszalska I; Wituła K
    Acta Pol Pharm; 2005; 62(2):83-8. PubMed ID: 16161346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of hydrolysis of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine in aqueous solutions.
    Muszalska I
    Farmaco; 2004 Jun; 59(6):437-42. PubMed ID: 15178305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glycine on pH changes and protein stability during freeze-thawing in phosphate buffer systems.
    Pikal-Cleland KA; Cleland JL; Anchordoquy TJ; Carpenter JF
    J Pharm Sci; 2002 Sep; 91(9):1969-79. PubMed ID: 12210044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical stability of pharmaceutical phosphate buffer solutions V. Precipitation behavior in phosphate buffer solutions.
    Hasegawa K; Hashi K; Okada R
    J Parenter Sci Technol; 1983; 37(2):38-44. PubMed ID: 6864406
    [No Abstract]   [Full Text] [Related]  

  • 18. Physicochemical stability of pharmaceutical phosphate buffer solutions II. Complexation behavior of Al(III) with additives in phosphate buffer solutions.
    Hasegawa K; Hashi K; Okada R
    J Parenter Sci Technol; 1982; 36(4):168-73. PubMed ID: 6813447
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics and mechanisms of vinpocetine degradation in aqueous solutions.
    Muhammad N; Adams G; Lee HK
    J Pharm Sci; 1988 Feb; 77(2):126-31. PubMed ID: 3361427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of irinotecan hydrochloride in aqueous solutions.
    Li WY; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):539-44. PubMed ID: 11908247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.